← Back to Discover
Aisling Capital Management LP
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $471,616,868
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- BRIDGEBIO PHARMA INC · COM · 10806X102 · shares: $341,834,227
- MONTE ROSA THERAPEUTICS INC · COM · 61225M102 · shares: $37,647,069
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $28,785,379
- COMPASS PATHWAYS PLC · SPONSORED ADS · 20451W101 · shares: $20,267,554
- BICARA THERAPEUTICS INC · COM · 055477103 · shares: $16,891,205
- BRIDGEBIO ONCOLOGY THERAPEUT · COM NEW · 107924102 · shares: $7,757,297
- SCHOLAR ROCK HLDG CORP · COM · 80706P103 · shares: $4,236,705
- UROGEN PHARMA LTD · COM · M96088105 · shares: $3,974,400
- BIOMEA FUSION INC · COM · 09077A106 · shares: $3,011,673
- ACLARIS THERAPEUTICS INC · COM · 00461U105 · shares: $2,298,267
Filing totals differ
The filing summary reports $471,616,868, while the holdings entries total $471,616,867.
Reported holdings
14 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 4,589,611 shares | $341,834,227 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 1,555,664 shares | $37,647,069 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,316,806 shares | $28,785,379 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 1,432,336 shares | $20,267,554 |
| BICARA THERAPEUTICS INC | COM | 055477103 | — | 568,919 shares | $16,891,205 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | — | 1,018,018 shares | $7,757,297 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 77,031 shares | $4,236,705 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 108,000 shares | $3,974,400 |
| BIOMEA FUSION INC | COM | 09077A106 | — | 2,048,757 shares | $3,011,673 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 434,455 shares | $2,298,267 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 325,000 shares | $2,148,250 |
| VTV THERAPEUTICS INC | CL A NEW | 918385204 | — | 50,000 shares | $1,882,500 |
| MARKER THERAPEUTICS INC | COM NEW | 57055L206 | — | 325,370 shares | $478,293 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 88,607 shares | $404,048 |